{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:39Z","timestamp":1793633499889,"version":"4.5.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Government Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103103","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:48:04Z","timestamp":1789688884000},"page":"103103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aptamer-guided delivery of miR-126 suppresses glioblastoma stem-like cell invasion and tumor progression"],"prefix":"10.1016","volume":"37","author":[{"given":"Giorgia","family":"Castellani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Buccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Affinito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Ilari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2079-7734","authenticated-orcid":false,"given":"Alessandra","family":"Di Giamberardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagiovanna","family":"Ballato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Offi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Mollinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Felli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Boe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Marziali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-9060","authenticated-orcid":false,"given":"Mauro","family":"Biffoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Caffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerolama","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-9291","authenticated-orcid":false,"given":"Quintino Giorgio","family":"D'Alessandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ricci-Vitiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103103_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omtn.2026.103103_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.omtn.2026.103103_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22261","article-title":"Targeted therapies for Glioblastoma multiforme (GBM): State-of-the-art and future prospects","volume":"85","author":"Satish","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.omtn.2026.103103_bib4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.103103_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092534","article-title":"Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies","volume":"12","author":"Balachandran","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omtn.2026.103103_bib6","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1111\/jcmm.17135","article-title":"miR-126-5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2\/BIRC axis","volume":"26","author":"Han","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.omtn.2026.103103_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12030745","article-title":"miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer","volume":"12","author":"Msheik","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.omtn.2026.103103_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/ol.2020.11687","article-title":"MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK\/MAPK signaling pathway","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omtn.2026.103103_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317709283","article-title":"The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab","volume":"39","author":"Fiala","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omtn.2026.103103_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-11-0272","article-title":"MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9","volume":"10","author":"Hamada","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omtn.2026.103103_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167984","article-title":"MicroRNA-126: A key regulator of angiogenesis, inflammation, and tumorigenesis - Exploring its multifaceted functions in vascular health and cancer","volume":"1871","author":"Wo\u017aniak","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.omtn.2026.103103_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.21037\/cdt-20-178","article-title":"MicroRNA-126 promotes endothelial progenitor cell proliferation and migration ability via the Notch pathway","volume":"10","author":"Kong","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.omtn.2026.103103_bib13","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.21873\/anticanres.11280","article-title":"Down-regulation of MicroRNA-126 in Glioblastoma and its Correlation with Patient Prognosis: A Pilot Study","volume":"36","author":"Han","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.omtn.2026.103103_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10689-015-9846-4","article-title":"Methylation of the miR-126 gene associated with glioma progression","volume":"15","author":"Cui","year":"2016","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.omtn.2026.103103_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115103","article-title":"LAT1, a novel pharmacological target for the treatment of glioblastoma","volume":"201","author":"Cappoli","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omtn.2026.103103_bib16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s43018-025-00985-4","article-title":"Glioblastoma shift from bulk to infiltrative growth is guided by plexin-B2-mediated microglia alignment in invasive niches","volume":"6","author":"Kang","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.omtn.2026.103103_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13059-020-02092-2","article-title":"PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas","volume":"21","author":"Noorani","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103103_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102485","article-title":"Aptamer-mediated delivery of therapeutic oligonucleotides in glioblastoma","volume":"60","author":"Castellani","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omtn.2026.103103_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.omtn.2019.08.015","article-title":"The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells","volume":"18","author":"Affinito","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103103_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.omtn.2020.02.005","article-title":"Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells","volume":"20","author":"Affinito","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103103_bib21","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.3171\/2012.12.FOCUS12351","article-title":"The Cancer Genome Atlas expression profiles of low-grade gliomas","volume":"36","author":"Gonda","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.omtn.2026.103103_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-016-2125-x","article-title":"Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures","volume":"128","author":"Halle","year":"2016","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.omtn.2026.103103_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056824","article-title":"miR-126&126\u2217 restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma","volume":"8","author":"Felli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103103_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/1878-0261.12047","article-title":"A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes","volume":"11","author":"Marziali","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omtn.2026.103103_bib25","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1111\/odi.14285","article-title":"Exosomes derived from stem cells from apical papilla promote angiogenesis via miR-126 under hypoxia","volume":"29","author":"Lin","year":"2023","journal-title":"Oral Dis."},{"key":"10.1016\/j.omtn.2026.103103_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2017.02.025","article-title":"Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma","volume":"394","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omtn.2026.103103_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.repbio.2018.07.005","article-title":"MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2","volume":"18","author":"Xiang","year":"2018","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.omtn.2026.103103_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41467-024-55056-6","article-title":"Invasion of glioma cells through confined space requires membrane tension regulation and mechano-electrical coupling via Plexin-B2","volume":"16","author":"Junqueira Alves","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103103_bib29","first-page":"1023","article-title":"MiR-126 enhances VEGF expression in induced pluripotent stem cell-derived retinal neural stem cells by targeting spred-1","volume":"11","author":"Ye","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.omtn.2026.103103_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.omtn.2026.103103_bib31","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/nar\/gkl388","article-title":"Aptamer mediated siRNA delivery","volume":"34","author":"Chu","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103103_bib32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2014.5","article-title":"Multifunctional aptamer-miRNA conjugates for targeted cancer therapy","volume":"22","author":"Esposito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103103_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101521","article-title":"Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer","volume":"11","author":"Nuzzo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2026.103103_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40291-025-00810-9","article-title":"Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery","volume":"29","author":"Brito","year":"2025","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.omtn.2026.103103_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1101\/gad.1839510","article-title":"Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure","volume":"24","author":"Phoenix","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2026.103103_bib36","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1101\/gad.341222.120","article-title":"SPRED proteins and their roles in signal transduction, development, and malignancy","volume":"34","author":"Lorenzo","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2026.103103_bib37","article-title":"MicroRNA-VEGF axis in gastric cancer: a novel therapeutic frontier","volume":"17","author":"Al-Omari","year":"2026","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.omtn.2026.103103_bib38","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.31983","article-title":"Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1","volume":"144","author":"Falchetti","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2026.103103_bib39","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1158\/1078-0432.CCR-08-0644","article-title":"Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme","volume":"14","author":"Pallini","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2026.103103_bib40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/ijc.33370","article-title":"Short tandem repeat profiling for the authentication of cancer stem-like cells","volume":"148","author":"Visconti","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2026.103103_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13046-025-03515-3","article-title":"DUSP8 as a regulator of glioblastoma stem-like cell contribution to tumor vascularization","volume":"44","author":"Castellani","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2026.103103_bib42","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20040921","article-title":"Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death","volume":"200","author":"Ricci-Vitiani","year":"2004","journal-title":"J. Exp. Med."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312600274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:15:37Z","timestamp":1793632537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312600274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S216225312600274X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103103","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer-guided delivery of miR-126 suppresses glioblastoma stem-like cell invasion and tumor progression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103103"}}